RenaMed Biologics

company

About

RenaMed Biologics engages in the development of therapies for the treatment of diseases associated with compromised kidney function.

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$40M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 1995
Operating Status
Active

RenaMed Biologics a biotechnology company, engages in the development and commercialization of therapies for the treatment of diseases associated with compromised kidney function. The company focuses on patients suffering from acute renal failure and additional indications where kidney function is compromised. It develops RBI-01, which utilizes physiologically active human renal epithelial cells and administered ex vivo, to replace and maintain severely compromised, or lost kidney functions due to illness, or trauma. The company was founded in 1995 as Nephros Therapeutics, Inc. and changed its name to RenaMed Biologics, Inc. in 2005. RenaMed Biologics, Inc. is based in Lincoln, Rhode Island.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$40M
RenaMed Biologics has raised a total of $40M in funding over 2 rounds. Their latest funding was raised on Sep 7, 2006 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 7, 2006 Series Unknown $40M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
RenaMed Biologics is funded by 1 investors. TSC BioVenture Capital Corporation are the most recent investors.
Investor Name Lead Investor Funding Round
TSC BioVenture Capital Corporation Series Unknown